Skip to main content
Caplight Logo









Neoenta

Neoenta

Boston, Massachusettsneoentadesign.com

Overview

Neoenta is a private venture capital firm founded by Namal Nawana that focuses on healthcare, specifically investing in and developing early-stage medical technology, diagnostics, and medical device companies.

Year Founded

2017

Portfolio Companies

1

Investments

Neoenta investments
CompanyDateStageLead
SapphirosJul 2021Corporate FundingCo-investor

Key People

Ziad Al-Shamsie

Chief Technology Officer

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Neoenta based?

Neoenta is headquartered in Boston, Massachusetts, United States.

When was Neoenta founded?

Neoenta was founded in 2017.

How many portfolio companies does Neoenta have?

Neoenta has 1 portfolio company in Caplight's dataset.

What are some companies in Neoenta's portfolio?

Portfolio companies visible on Caplight include Sapphiros.

What was Neoenta's most recent investment shown here?

Neoenta's most recent investment in this portfolio sample was in Sapphiros in 2021.

What sectors does Neoenta focus on?

Neoenta focuses on Healthcare & Life Sciences.

What company stages does Neoenta focus on?

Stage focus information for Neoenta is not publicly available.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?